251 related articles for article (PubMed ID: 9154872)
1. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.
Wells AU; Hansell DM; Rubens MB; Cailes JB; Black CM; du Bois RM
Am J Respir Crit Care Med; 1997 May; 155(5):1657-64. PubMed ID: 9154872
[TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
[TBL] [Abstract][Full Text] [Related]
3. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
[TBL] [Abstract][Full Text] [Related]
4. Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography.
Wells AU; Rubens MB; du Bois RM; Hansell DM
Eur Respir J; 1997 Feb; 10(2):280-5. PubMed ID: 9042621
[TBL] [Abstract][Full Text] [Related]
5. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography.
Wells AU; Hansell DM; Rubens MB; King AD; Cramer D; Black CM; du Bois RM
Arthritis Rheum; 1997 Jul; 40(7):1229-36. PubMed ID: 9214422
[TBL] [Abstract][Full Text] [Related]
6. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans.
Chan TY; Hansell DM; Rubens MB; du Bois RM; Wells AU
Thorax; 1997 Mar; 52(3):265-70. PubMed ID: 9093344
[TBL] [Abstract][Full Text] [Related]
7. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography.
Wells AU; King AD; Rubens MB; Cramer D; du Bois RM; Hansell DM
Am J Respir Crit Care Med; 1997 Apr; 155(4):1367-75. PubMed ID: 9105081
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis.
Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM
Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462
[TBL] [Abstract][Full Text] [Related]
9. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.
Wells AU; Hansell DM; Rubens MB; Cullinan P; Haslam PL; Black CM; Du Bois RM
Am J Respir Crit Care Med; 1994 Aug; 150(2):462-8. PubMed ID: 8049830
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis.
Southcott AM; Jones KP; Li D; Majumdar S; Cambrey AD; Pantelidis P; Black CM; Laurent GJ; Davies BH; Jeffery PK
Am J Respir Crit Care Med; 1995 May; 151(5):1604-12. PubMed ID: 7735620
[TBL] [Abstract][Full Text] [Related]
11. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.
Wells AU; Hansell DM; Rubens MB; Cullinan P; Black CM; du Bois RM
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1076-82. PubMed ID: 8214928
[TBL] [Abstract][Full Text] [Related]
13. Exhaled nitric oxide is increased in active fibrosing alveolitis.
Paredi P; Kharitonov SA; Loukides S; Pantelidis P; du Bois RM; Barnes PJ
Chest; 1999 May; 115(5):1352-6. PubMed ID: 10334152
[TBL] [Abstract][Full Text] [Related]
14. Interstitial vascularity in fibrosing alveolitis.
Renzoni EA; Walsh DA; Salmon M; Wells AU; Sestini P; Nicholson AG; Veeraraghavan S; Bishop AE; Romanska HM; Pantelidis P; Black CM; Du Bois RM
Am J Respir Crit Care Med; 2003 Feb; 167(3):438-43. PubMed ID: 12406847
[TBL] [Abstract][Full Text] [Related]
15. The value of high definition, narrow section computed tomography in fibrosing alveolitis.
Strickland B; Strickland NH
Clin Radiol; 1988 Nov; 39(6):589-94. PubMed ID: 3243050
[TBL] [Abstract][Full Text] [Related]
16. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.
Wells AU; Rubens MB; du Bois RM; Hansell DM
AJR Am J Roentgenol; 1993 Dec; 161(6):1159-65. PubMed ID: 8249719
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
Bouros D; Wells AU; Nicholson AG; Colby TV; Polychronopoulos V; Pantelidis P; Haslam PL; Vassilakis DA; Black CM; du Bois RM
Am J Respir Crit Care Med; 2002 Jun; 165(12):1581-6. PubMed ID: 12070056
[TBL] [Abstract][Full Text] [Related]
18. Cryptogenic fibrosing alveolitis with preserved lung volumes.
Doherty MJ; Pearson MG; O'Grady EA; Pellegrini V; Calverley PM
Thorax; 1997 Nov; 52(11):998-1002. PubMed ID: 9487350
[TBL] [Abstract][Full Text] [Related]
19. PET scanning of macrophages in patients with scleroderma fibrosing alveolitis.
Branley HM; du Bois RM; Wells AU; Jones HA
Nucl Med Biol; 2008 Nov; 35(8):901-9. PubMed ID: 19026952
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis.
Avila JJ; Lympany PA; Pantelidis P; Welsh KI; Black CM; du Bois RM
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):106-12. PubMed ID: 9870923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
